Antiproliferative effects of the arotinoid Ro 40-8757 in human gastrointestinal and pancreatic cancer cell lines: combinations with 5-fluorouracil and interferon-a
1996

Effects of Ro 40-8757 on Cancer Cells

Sample size: 9 publication Evidence: moderate

Author Information

Author(s): C Louvet, S Djelloull, M-E Forgue-Lafittel, J Mester, A Zimber, C Gespach

Primary Institution: Hôpital Saint-Antoine, Paris, France

Hypothesis

Can the arotinoid Ro 40-8757 inhibit the growth of gastrointestinal and pancreatic cancer cell lines when combined with 5-fluorouracil and interferon-a?

Conclusion

Ro 40-8757 effectively inhibits the growth of various gastrointestinal and pancreatic cancer cell lines, especially when used in combination with 5-fluorouracil and interferon-a.

Supporting Evidence

  • Ro 40-8757 inhibited cell proliferation in a dose-dependent manner across all tested cancer cell lines.
  • The IC50 values for Ro 40-8757 were below 10-6 M for most cell lines.
  • Combinations of Ro 40-8757 with 5FU and interferon-a showed additive effects on cell growth inhibition.

Takeaway

Ro 40-8757 is a new medicine that helps stop cancer cells from growing, and it works even better when mixed with other cancer drugs.

Methodology

The study tested the effects of Ro 40-8757 on nine human cancer cell lines, measuring cell growth inhibition and analyzing cell cycle distribution.

Limitations

The study's in vitro results may not predict in vivo outcomes, and the concentrations used may not be achievable in patients without toxicity.

Statistical Information

P-Value

<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication